Rituximab in idiopathic membranous nephropathy: a one-year prospective study.
about
Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case reportImmunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndromeHuman Urine Proteomics: Analytical Techniques and Clinical Applications in Renal DiseasesCoexistence of immune thrombocytopenic purpura and idiopathic membranous glomerulonephritis successfully treated with rituximab.Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantationControversies in the treatment of idiopathic membranous nephropathy.Experimental membranous nephropathy reduxRituximab therapy in idiopathic membranous nephropathy: a 2-year study.Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.Steroid-sensitive nephrotic syndrome in children: triggers of relapse and evolving hypotheses on pathogenesis.The contribution of B cells to renal interstitial inflammationRituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients.A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study.Rituximab in idiopathic membranous nephropathy.Treatment of idiopathic membranous nephropathy.The emerging role of rituximab in organ transplantation.Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?Depletion of B lymphocytes in idiopathic membranous glomerulopathy: results from patients with extended follow-upLow- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study.Latest treatment strategies for membranous nephropathy.American Society of Nephrology Quiz and Questionnaire 2012: glomerulonephritisRituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trialSuccessful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patientsRituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosisProliferative glomerulonephritis with monoclonal IgG deposits.Rituximab therapy for membranous nephropathy: a systematic reviewMembranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab.Treatment with rituximab in idiopathic membranous nephropathy.Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?Update on the role of rituximab in kidney diseases and transplant.Membranous nephropathy: the start of a paradigm shift.Rituximab in immunologic glomerular diseases.Rituximab: emerging treatment strategies of immune-mediated glomerular disease.B-cell-targeted therapy in adult glomerulonephritis.B cell depletion: rituximab in glomerular disease and transplantationOverview of current and alternative therapies for idiopathic membranous nephropathy.Biologic agents in the treatment of glomerulonephritides.Clinical and treatment-related features determining the risk of late relapse in patients with diffuse large B-cell lymphoma.Treatment of membranous nephropathy: time for a paradigm shift.Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.
P2860
Q21202088-B8B2B358-5626-49C5-9E22-3D8E62CBB137Q24246172-BFBD3824-6A90-471D-B4FD-072FF19E2516Q26773607-63CD49E4-2F1F-4037-B789-B393A5782CFCQ33390691-BBCAEA94-86CA-4FA3-A37B-9A3E60CA016CQ33827375-1DE18938-CE28-4109-8ACB-CCB519535939Q34248343-B0A0FB6E-D495-4763-9BF5-685DE91D686BQ34248969-D56B9114-8C9B-44B9-BB46-6A0972AFCDE9Q34362660-A5EFE06E-92E1-49E8-9F5E-C8240E8D012FQ34656882-4C7E52CD-6111-4AB1-B0FE-B3860F94B90EQ35233125-09ACE9BF-11B9-4386-B2EC-1C4559585758Q35750182-0A31C382-454C-4679-B9AF-2A9200F2692CQ35791799-9D1E8DAC-80D2-4330-85F2-E21519F46E54Q36088887-B57C5430-32AD-4F4A-ABC8-EAA7A52F1BDFQ36109197-B1FF0D61-012D-4A14-B164-9A911733FF65Q36280345-A2EDEE17-43FD-4C73-9036-B79F2BDECDABQ36530278-2048133E-C067-4274-8F2E-B943F0D8292EQ36577362-9820B978-C8A9-4B1E-BA26-D8A7CA21EB8EQ36596888-BE6355F4-2EE7-4989-9F5B-933FADFC8F77Q36741001-8AA5D726-58B8-47C2-98CF-398B11D2E8F5Q37013035-07EC2CC5-5EB7-4557-9CB3-302E73A97766Q37065581-94C574A7-657A-4DC2-BB17-F0E0D9F9D883Q37144563-F9A7B262-1FC4-4FD2-A060-94173BB342F3Q37211086-DC883DC6-A84C-49BC-B464-F54424ACE981Q37297636-D1602875-2499-44A5-A349-30C21B6DE505Q37330535-2A2C13E8-F674-41C0-B2A0-D812B828417FQ37412829-ED57358B-0E27-4092-A41B-5AC2432F67B0Q37475696-790C0751-95FB-463F-A0AC-63BE2BD0C8F5Q37511019-AC3E54F8-6E2F-44EC-8725-811006798B32Q37709432-C7446C48-FB68-4C49-95A4-10FD1D753AF7Q37970443-0C005171-3209-406B-81DD-9D5AA3699EA8Q37975360-BEBFC9D1-58BE-4728-9602-E6D1E63FD3A7Q37989298-A353EE94-74FA-4E19-800B-3BA4142910FDQ38033648-15BBB75F-BBD6-49B5-8625-596D39178CC3Q38159787-F6B38544-BDB2-45BB-AD02-C77418C109E0Q38189360-2EA7A5A7-DC11-4AA0-B942-6D4327B91DFBQ38425865-368AA9CA-9367-4ACF-9BC0-A7F20A9A04CCQ38514894-B4206E12-4056-472D-9A03-4BB339AFF6A3Q38707700-6E34DB99-ECD8-4C74-B63A-4DAC90A93DFDQ39410091-622F7A59-AA83-49CB-8F18-1F785D60AB80Q39648546-39C67783-6BAB-434F-BB01-2D9CE0DDBBB2
P2860
Rituximab in idiopathic membranous nephropathy: a one-year prospective study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Rituximab in idiopathic membranous nephropathy: a one-year prospective study.
@en
Rituximab in idiopathic membranous nephropathy: a one-year prospective study.
@nl
type
label
Rituximab in idiopathic membranous nephropathy: a one-year prospective study.
@en
Rituximab in idiopathic membranous nephropathy: a one-year prospective study.
@nl
prefLabel
Rituximab in idiopathic membranous nephropathy: a one-year prospective study.
@en
Rituximab in idiopathic membranous nephropathy: a one-year prospective study.
@nl
P2093
P50
P1476
Rituximab in idiopathic membranous nephropathy: a one-year prospective study.
@en
P2093
Carlos Chiurchiu
Claudia Filippi
Mauro Abbate
Varusca Brusegan
P304
P356
10.1097/01.ASN.0000071511.35221.B3
P577
2003-07-01T00:00:00Z